SEC Form 4 · accession 0001209191-16-113799
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin E Cearnal
Officer — Sr VP/Chief Commercial Officer · Director
Period of report
Apr 6, 2016
Accepted (ET)
Apr 8, 2016 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 6, 2016 | A | 4,000 | $4.34 | A | 135,856 | D | |
| Common StockF2 | Apr 6, 2016 | F | 980 | $4.34 | D | 134,876 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on March 18, 2020.
- F2This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 3,000 shares during March 2016